Trial · NCT04728932
LEVOSIMENDAN to Facilitate Weaning From ECMO in Severe Cardiogenic Shock Patients
NCT04728932, Phase 3, Completed, Assistance Publique - Hôpitaux de Paris
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. LEVOSIMENDAN to Facilitate Weaning From ECMO in Severe Cardiogenic Shock Patients. Trials, record NCT04728932. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04728932
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- LEVOSIMENDAN to Facilitate Weaning From ECMO in Severe Cardiogenic Shock Patients
- NCT number
- NCT04728932
- Status
- Completed
- Phases
- Phase 3
- Enrollment
- 206 participants, actual
- Lead sponsor
- Assistance Publique - Hôpitaux de Paris
- Conditions
- Cardiogenic Shock, Extracorporeal Membrane Oxygenation Complication
- Interventions
- Levosimendan, Placebo of Levosimendan
- First posted
- 2021-01-28
- Last updated
- 2025-03-21
- Other registries' IDs
- eudract:2019-004319-29
Source ClinicalTrials.gov
Registered outcomes16
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Time to successful ECMO weaning within the 30 days following randomization | Day 30 | |
| Secondary | Mortality | Day 30, Day 60 | |
| Secondary | Total duration of ECMO support | Between inclusion and Day 30/Day 60 | |
| Secondary | Number of ECMO-free days | Between inclusion and Day 30/Day 60 | |
| Secondary | Duration of ICU stay | Between inclusion and Day 60 | |
| Secondary | Duration of hospitalization stay | Between inclusion and Day 60 | |
| Secondary | Major adverse cardiovascular events | Day 30, Day 60 | defined as death, cardiac transplant, escalation to permanent left ventricular assist device, stroke, dialysis, re-hospitalization for heart failure |
| Secondary | Time to improvement in hemodynamic parameters | Between inclusion and Day 60 | |
| Secondary | Time to hemodynamic stabilization | Between inclusion and Day 60 | |
| Secondary | Days with organ failure asessed by sequential organ failure assessment | Between inclusion and Day 30 |
1 to 10 of 16Source ClinicalTrials.gov
See all 16 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 41324946 | DERIVED |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT04728932
GET https://conductscience.org/api/trials/v1/NCT04728932/registered